Trials / Completed
CompletedNCT02467348
Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
To Study the Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
All consecutive patients admitted in ILBS from MAY 2015 to DECEMBER 2016.ACLF (Acute on chronic Liver Failure). ACLF will be randomize into Group 1: MVP (Modest Volume Paracentesis) OF Less than 5 liters with IV albumin at a dose 8 gms/L of ascitic fluid Group 2: MVP (Modest Volume Paracentesis) of Less than 5 liters without albumin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Albumin | Intravenous albumin 8 gms/L of ascitic fluid |
| DRUG | Ascitic fluid |
Timeline
- Start date
- 2015-03-15
- Primary completion
- 2017-01-31
- Completion
- 2017-01-31
- First posted
- 2015-06-10
- Last updated
- 2017-11-28
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02467348. Inclusion in this directory is not an endorsement.